Supplementary Table 6A from High <i>ALK</i> Receptor Tyrosine Kinase Expression Supersedes <i>ALK</i> Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
Neuroblastoma in advanced stages is among the most intractable pediatric cancers, even with the recent therapeutic advances. Neruroblastoma harbours a variety of genetic changes, including a high freq
Patients older than 18 months of age with stage 3, MYCN-non-amplified, unfavorable histology neuroblastoma represent a rare subset of children with outcomes that are inferior to those of most patients
Differential Expression Results. This spreadsheet contains the results of limma analysis on RNA-seq-MAV data. The data for the top 500 genes with smallest adjusted p-values are included. The columns i
